BridgeMD
Compares treatment options for Blunt Cerebrovascular Injury
Official title Stroke Rate in Patients With Blunt Cerebrovascular Injury (BCVI) Treated With Oral Acetylsalicylic Acid (ASA) 81 mg Versus ASA 325 mg (BASA).
ClinicalTrials.gov ID: NCT05868525
What this study is testing
What is Aspirin 325Mg Tab, Aspirin 81Mg Tab?
Aspirin 325Mg Tab, Aspirin 81Mg Tab is an investigational medicine, given as an once-daily pill taken by mouth, being studied as a potential treatment for blunt cerebrovascular injury.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this clinical trial is to compare difference between Aspirin 81 mg and Aspirin 325 mg in preventing strokes in patients with head and neck vessels injury. The main questions it aims to answer are: If Aspirin 81 mg efficacy in prevention of stroke in patients with head and neck vessels injury is not lower than and Aspirin 325 mg.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥18
- All patients with blunt cerebrovascular injury are diagnosed by computed tomography angiography (CTA) upon admission
You likely can't join if
- Age \<18
- Pregnant women
- No enteral route access for Aspirin administration
- Patients who are on Heparin drip or other full dose anticoagulation when BCVI diagnosed
- Patients who are on other Anti-Platelets aside from Aspirin when BCVI diagnosed
- Patients with BCVI grade 5 injury based on Biffl classification
See the full eligibility criteria
- Age ≥18
- All patients with blunt cerebrovascular injury are diagnosed by computed tomography angiography (CTA) upon admission
- Age \<18
- Pregnant women
- No enteral route access for Aspirin administration
- Patients who are on Heparin drip or other full dose anticoagulation when BCVI diagnosed
- Patients who are on other Anti-Platelets aside from Aspirin when BCVI diagnosed
- Patients with BCVI grade 5 injury based on Biffl classification
- Presence of any contraindication or history of allergy to Aspirin
- Patient with the diagnosis of acute stroke at the time of BCVI diagnosis matching the injured vessel territory on imaging
- Patients with acute spinal trauma that needs surgical intervention
The study team makes the final eligibility decision.
Where it's taking place
- Loma Linda, California, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Loma Linda, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.